Subscribe

Middle East Healthcare Company (4009.SR)

SAR31.80 -0.14 (-0.44%)
SA SAU Healthcare Medical - Care Facilities
Address 4, Batterjee Road 21461
Jeddah, Makkah Province, SA
CEO Nezar Mohammed Sultan Bahabri
Website sghgroup.com.sa
IPO 2016-03-29
ISIN SA141H01UKH9

Explore sections of this company profile

Description

Middle East Healthcare Company is a prominent medical service provider that manages and operates an extensive network of Saudi German Hospitals throughout the Middle East and North Africa region. These facilities offer comprehensive multi-specialty tertiary care. The company's diverse hospital portfolio includes Saudi German Hospital-Jeddah with 218 beds, Saudi German Hospital-Aseer featuring 400 beds, Saudi German Hospital-Riyadh and Saudi German Hospital-Madinah each equipped with 300 beds, and Saudi German Hospital-Hail providing 150 beds. Expanding its reach further, the network also encompasses Saudi German Hospital-Dammam, offering 150 to 300 beds; Saudi German Hospital-Sanaa and Saudi German Hospital-Dubai, both with 300 beds; Saudi German Hospital-Sharjah, a 50-bed facility; Saudi German Hospital-Ajman, which has between 100 and 200 beds; and Saudi German Hospital-Cairo, accommodating 332 patients. Established in 1988, the company's primary corporate base is situated in Jeddah, Kingdom of Saudi Arabia.

Market Cap & Enterprise Value
Merger & Acquisition History

No mergers or acquisitions recorded for this company.

Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary Loading…
Indicator 1D1W2W3W1M
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
Averages
Trend
Price
Levels
Draw
SAR31.80 -0.14 (-0.44%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
638.0K
Beta
-0.05
Float Shares
40.81M
Free Float %
44.3%
Price Performance
1D5D1M3M6M YTD1Y3Y5Y10YMax
+0.00% +0.00% -7.96% +13.27% -13.58% +4.36% -41.21% -42.11% -10.34% -50.47% -51.63%
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
vs.
Loading histogram data…

Revenue flow

Revenue by geography

Revenue by segment

From To

Revenue composition

From To

By product

By geography

Financial Statements

Income Statement

Balance Sheet

Cash Flow Statement

Key Metrics

Financial Ratios

Employees

Financial Growth (CAGR)

Market Data

Price Targets & DCF
Current price
31.80
DCF (Unlevered) 246.51 +675.2%
DCF (Levered) 219.82 +591.2%

DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.

Ratings Trend (MoM) 25% Bullish
Rating 2026-05 Change
Strong Buy 0 0
Buy 1 0
Hold 3 0
Sell 0 0
Strong Sell 0 0
Quality scores
Altman Z-Score
1.60
Distress
Piotroski F-Score
7 / 9
Strong
MOAT Score
4 / 10
Developing
Operational MOAT
✗ Below peers
  • ✓
    Revenue growth Medical - Care Facilities: +10.2%
    +7.6% Q1'26: +4.3% (vs Q1'25)
  • ✓
    EPS growth Medical - Care Facilities: +19.2%
    +7.2% Q1'26: -83.9% (vs Q1'25)
  • ✓
    FCF margin FCF growth · Medical - Care Facilities: +32.0%
    +0.7% Q1'26: +11.8% (vs Q1'25)
  • ✗
    EBIT margin Medical - Care Facilities: +11.3%
    +12.6% ★ Q1'26: +9.7% (vs Q1'25)
  • ✗
    ROIC Medical - Care Facilities: +6.8%
    +8.4% ★ Q1'26: +5.6% (vs Q1'25)
  • ✓
    Share dilution Medical - Care Facilities: +0.0%
    +0.0% Q1'26: -0.3% (vs Q1'25)
  • ✗
    Debt / EBITDA Net debt/EBITDA · Medical - Care Facilities: 0.99×
    4.00× Q1'26: 4.62× (vs Q1'25)
Valuation Multiples From To
Price Forecast (3Y) From To
Model
Adjust
P/E
Theoretical Return — If Invested Today

* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.

DCF Interactive Model (UFCF)
Projection years:
Market assumptions
▶ WACC components (optional)
Ke (Cost of Equity) = Rf + β (0.00) × ERP
WACC = 55% × Ke + 45% × Kd (7.9%) × (1−t)

Modifying these values recalculates WACC automatically.

Business assumptions
—
Intrinsic value (base): 246.51 Current price: 31.80
Enterprise Value: — Equity Value: — Terminal Value: — TV as % of EV: —

Base values reflect the latest available data for this company and market conditions.

Consensus Estimates
Metric Dec 2016
actual 		Dec 2017
actual 		Dec 2018
actual 		Dec 2019
actual 		Dec 2020
actual 		Dec 2021
actual 		Dec 2022
actual 		Dec 2023
actual 		Dec 2024
actual 		Dec 2025
actual 		Dec 2026
1 Rev. Ana.
1 EPS Ana. 		Dec 2027
1 Rev. Ana.
1 EPS Ana. 		Dec 2028
2 Rev. Ana.
1 EPS Ana. 		Dec 2029
1 Rev. Ana.
1 EPS Ana. 		Dec 2030
1 Rev. Ana.
1 EPS Ana.
Revenue
1.62B
est: 1.65B (-2.1%)
1.63B
est: 1.64B (-0.9%)
1.39B
est: 1.45B (-3.8%)
1.50B
est: 1.47B (+2.0%)
1.77B
est: 1.80B (-1.3%)
1.87B
est: 1.89B (-0.9%)
2.15B
est: 2.11B (+2.0%)
2.65B
est: 2.79B (-5.0%)
2.88B
est: 2.92B (-1.3%)
3.10B
est: 3.10B (0.0%)
3.37B
3.37B – 3.37B
+8.8% YoY
3.65B
3.65B – 3.65B
+8.1% YoY
3.86B
3.80B – 3.93B
+5.9% YoY
4.05B
4.05B – 4.05B
+4.9% YoY
4.18B
4.18B – 4.18B
+3.2% YoY
EBITDA
421.96M
est: 275.77M (+53.0%)
387.89M
est: 274.77M (+41.2%)
251.68M
est: 241.61M (+4.2%)
201.68M
est: 245.14M (-17.7%)
243.83M
est: 300.09M (-18.7%)
195.65M
est: 315.88M (-38.1%)
286.31M
est: 352.42M (-18.8%)
533.93M
est: 971.60M (-45.0%)
747.50M
est: 1.02B (-26.4%)
636.54M
est: 1.08B (-41.0%)
1.17B
1.17B – 1.17B
+8.8% YoY
1.27B
1.27B – 1.27B
+8.1% YoY
1.34B
1.32B – 1.37B
+5.9% YoY
1.41B
1.41B – 1.41B
+4.9% YoY
1.45B
1.45B – 1.45B
+3.2% YoY
EBIT
376.71M
est: 156.35M (+140.9%)
309.83M
est: 155.78M (+98.9%)
180.93M
est: 136.99M (+32.1%)
103.27M
est: 138.99M (-25.7%)
107.41M
est: 170.14M (-36.9%)
54.24M
est: 179.10M (-69.7%)
140.34M
est: 199.81M (-29.8%)
344.12M
est: 739.73M (-53.5%)
530.75M
est: 773.71M (-31.4%)
390.59M
est: 821.91M (-52.5%)
893.87M
893.87M – 893.87M
+8.8% YoY
966.36M
966.36M – 966.36M
+8.1% YoY
1.02B
1.01B – 1.04B
+5.9% YoY
1.07B
1.07B – 1.07B
+4.9% YoY
1.11B
1.11B – 1.11B
+3.2% YoY
Net Income
361.86M
est: 383.25M (-5.6%)
300.08M
est: 277.04M (+8.3%)
172.25M
est: 183.54M (-6.2%)
97.57M
est: 107.58M (-9.3%)
81.99M
est: 114.74M (-28.5%)
11.73M
est: 55.68M (-78.9%)
75.18M
est: 63.38M (+18.6%)
180.18M
est: 202.91M (-11.2%)
282.00M
est: 238.15M (+18.4%)
301.88M
est: 316.30M (-4.6%)
162.29M
162.29M – 162.29M
-48.7% YoY
232.24M
232.24M – 232.24M
+43.1% YoY
282.86M
282.86M – 282.86M
+21.8% YoY
344.83M
344.83M – 344.83M
+21.9% YoY
428.43M
428.43M – 428.43M
+24.2% YoY
SGA
464.89M
est: 172.97M (+168.8%)
93.98M
est: 172.34M (-45.5%)
324.14M
est: 151.55M (+113.9%)
68.75M
est: 153.76M (-55.3%)
118.65M
est: 188.23M (-37.0%)
148.38M
est: 198.13M (-25.1%)
114.35M
est: 221.05M (-48.3%)
661.23M
est: 255.37M (+158.9%)
217.95M
est: 267.10M (-18.4%)
—
est: 283.74M (-100.0%)
308.58M
308.58M – 308.58M
+8.8% YoY
333.61M
333.61M – 333.61M
+8.1% YoY
353.15M
347.29M – 359.00M
+5.9% YoY
370.46M
370.46M – 370.46M
+4.9% YoY
382.27M
382.27M – 382.27M
+3.2% YoY
EPS
3.94
est: 4.16 (-5.4%)
3.47
est: 3.01 (+15.3%)
1.87
est: 1.99 (-6.2%)
1.06
est: 1.17 (-9.3%)
0.89
est: 1.25 (-28.6%)
0.13
est: 0.61 (-78.5%)
0.82
est: 0.69 (+19.6%)
1.96
est: 2.20 (-11.1%)
3.06
est: 2.59 (+18.3%)
3.28
est: 3.44 (-4.6%)
1.76
1.76 – 1.76
-48.7% YoY
2.52
2.52 – 2.52
+43.1% YoY
3.07
3.07 – 3.07
+21.8% YoY
3.75
3.75 – 3.75
+21.9% YoY
4.66
4.66 – 4.66
+24.2% YoY
Historical Ratings (3M)
Date Rating Overall DCF ROE ROA D/E P/E P/B
2026-05-21 B+ 3/5 5/5 4/5 4/5 1/5 2/5 3/5
2026-05-20 B+ 3/5 5/5 4/5 4/5 1/5 2/5 3/5
2026-05-19 B+ 3/5 5/5 4/5 4/5 1/5 2/5 3/5
2026-05-18 B+ 3/5 5/5 4/5 4/5 1/5 2/5 3/5
2026-05-17 C 2/5 5/5 1/5 1/5 1/5 2/5 1/5
2026-05-14 C 2/5 5/5 1/5 1/5 1/5 2/5 1/5
2026-05-13 C 2/5 5/5 1/5 1/5 1/5 2/5 1/5
2026-05-12 C 2/5 5/5 1/5 1/5 1/5 2/5 1/5
2026-05-11 C+ 2/5 5/5 1/5 1/5 1/5 3/5 1/5
2026-05-10 C+ 2/5 5/5 1/5 1/5 1/5 3/5 1/5
2026-05-07 B+ 3/5 1/5 4/5 4/5 1/5 4/5 4/5
2026-05-06 B+ 3/5 1/5 4/5 4/5 1/5 4/5 4/5
2026-05-05 B+ 3/5 1/5 4/5 4/5 1/5 4/5 4/5
2026-05-04 B+ 3/5 1/5 4/5 4/5 1/5 4/5 4/5
2026-05-03 B+ 3/5 1/5 4/5 4/5 1/5 4/5 4/5
2026-04-30 B+ 3/5 1/5 4/5 4/5 1/5 4/5 4/5
2026-04-29 B+ 3/5 1/5 4/5 5/5 1/5 4/5 4/5
2026-04-28 B+ 3/5 1/5 4/5 5/5 1/5 4/5 4/5
2026-04-27 B+ 3/5 1/5 4/5 5/5 1/5 4/5 4/5
2026-04-26 B+ 3/5 1/5 4/5 5/5 1/5 4/5 4/5
2026-04-23 B+ 3/5 1/5 4/5 5/5 1/5 3/5 4/5
2026-04-22 B+ 3/5 1/5 4/5 5/5 1/5 3/5 4/5
2026-04-21 B+ 3/5 1/5 4/5 5/5 1/5 3/5 4/5
2026-04-20 B+ 3/5 1/5 4/5 5/5 1/5 3/5 4/5
2026-04-19 B+ 3/5 1/5 4/5 5/5 1/5 3/5 4/5
2026-04-16 B+ 3/5 1/5 4/5 5/5 1/5 3/5 4/5

Owner Earnings

Owner's Earnings (history) From To
Owner alignment
Owner's Earnings TTM
109.57M
OE per share TTM
0.95
Owner's Yield
3.51%
Maintenance CapEx ratio
462.55%
Maint CapEx / Avg PPE
110.0%

Ownership Overview

Ownership breakdown

Ownership breakdown not available.

At a glance
Institutional holders
—
Total invested
—
Insider transactions (90d)
0
Beneficial owners (>5%)
0
Beneficial owners (>5%)

No beneficial ownership filings recorded.

Institutional Activity (13F)

Institutional ownership trend

Institutional history not available.

Top institutional holders

Top holders not available.

ETF Ownership

Top ETFs holding this stock Held by 49 ETFs in our universe
# ETF Weight Est. AUM exposure TER
1 iShares MSCI Saudi Arabia ETF KSA 0.14% 927.4K 0.75%
2 iShares MSCI Emerging Markets Small-Cap ETF EEMS 0.03% 98.8K 0.72%
3 Avantis Emerging Markets Small Cap Equity ETF AVEE 0.02% 29.3K 0.42%
4 iShares MSCI EM Small Cap UCITS ETF IEMS.L 0.02% 71.6K 0.74%
5 State Street SPDR MSCI Emerging Markets Small Cap UCITS ETF EMSD.L 0.02% 104.6K 0.55%
6 Vanguard FTSE All-World ex-US Small-Cap ETF VSS 0.01% 1.42M 0.06%
7 Dimensional - Emerging Markets Core Equity 2 ETF DFEM 0.01% 875.1K 0.39%
8 Dimensional - Emerging Markets ex China Core Equity ETF DEXC 0.01% 19.8K 0.56%
9 Avantis Emerging Markets Equity ETF AVEM 0.01% 1.43M 0.33%
10 Avantis Emerging Markets Equity UCITS ETF USD Acc AVEM.L 0.01% 13.5K 0.35%

Insider Activity

Insider Activity — Latest Quarter

No insider activity available.

Insider buys vs sells (history)

Insider history not available.

Recent insider transactions

No recent insider transactions.

Executive team

Top executives
EBIT / Employee
90.4K
Shares Outstanding
92.04M

Executive compensation

Executive compensation (annual)

Executive compensation not available.

CEO compensation breakdown

No CEO compensation history available.

Proxy statements

Proxy statements (DEF 14A)

No proxy statements available for this company yet.

Recent SEC filings

Recent SEC filings

No SEC filings available for this company yet.

Executive team

NameTitleCompensationGender
Abdul Rahman Rasheed Bakhsh Chief Operating Officer — —
Baraa Saleh Bakor Chief HR Officer — male
Hani Mustafa Abdulsalam Marketing Manager — —
Mansour Ahmed Aljanadi Chief Medical Officer — —
Nezar Mohammed Sultan Bahabri CEO & Manager — —
Sultan Adel Kamil Sindi Chief Financial Officer — —
ESG Score History

No data available for this company.

Senate Trading Activity

No Senate trading activity found for this company.

House Trading Activity

No House trading activity found for this company.

Market share among peers
Peer comparison — filtered group (TTM)
Your opinion

Share your view on this stock and instantly see how the community has voted over the last 6 months.

These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.

Dividend yield history

Dividend history

Earnings history

Earnings reports

Stock splits

Related companies

Largest companies in Medical - Care Facilities